Status and trend analysis of prophylactic usage of recombinant factor VIII in Chinese pediatric patients with hemophilia A: ReCare – a retrospective, phase IV, non-interventional study

Changgang LiDepartment of Hematology and Oncology, Shenzhen Children’s Hospital, Shenzhen, China;

Xinsheng ZhangHemophilia Treatment Centre, Shandong Blood Centre, Jinan, China;

Yongqiang ZhaoDepartment of Hematology, Peking Union Medical College Hospital, Beijing, China; Correspondence[email protected]

Runhui WuHematology/Oncology Centre, Beijing Children’s Hospital, Capital Medical University, Beijing, China;

Qun HuDepartment of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology (HUST), Hankou, Wuhan, China;

Vicky XuDepartment of Hematology, The Children’s Hospital, Zhengjiang University School of Medicine, Hangzhou, China;

Jing SunDepartment of Hematology, Nan fang Hospital, Southern Medical University, Guangzhou, China;

Renchi YangThrombosis and Hemostasis Centre, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China;

Xiaojing LiDepartment of Hematology, Chengdu Women & Children’s Central Hospital, Chengdu, China;

Rongfu ZhouDepartment of Hematology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China;

Shinmei LianDepartment of Hematology, Dalian Municipal Central Hospital, Dalian Medical University, Dalian, China;

Jian GuDepartment of Hematology, Northern Jiangsu People’s Hospital, Clinical Medical School of Yangzhou University, Yangzhou, China;

Junde WuBayer HealthCare Pharmaceuticals Inc., Beijing, China

Qingsong HouBayer HealthCare Pharmaceuticals Inc., Beijing, China

show all

Status and trend analysis of prophylactic usage of recombinant factor VIII in Chinese pediatric patients with hemophilia A: ReCare – a retrospective, phase IV, non-interventional study

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Status and trend analysis of prophylactic usage of recombinant factor VIII in Chinese pediatric patients with hemophilia A: ReCare – a retrospective, phase IV, non-interventional study

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date